New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on November 12, 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Lilly Endowment Inc, a significant shareholder of Eli Lilly & Co, has recently sold a total of 299,000 shares of the company’s stock. The transactions include the sale of 16,869 shares valued at $16,405,268 and an additional 283,131 shares worth $279,346,480. These sales highlight substantial financial movements within the company’s shareholder base.
Spark’s Take on LLY Stock
According to Spark, TipRanks’ AI Analyst, LLY is a Outperform.
Eli Lilly & Co’s strong financial performance and positive earnings call sentiment are the most significant factors driving the score. The company’s robust revenue growth, market share gains, and strategic pipeline advancements are key strengths. However, high leverage, declining cash flow metrics, and a premium valuation present potential risks.
To see Spark’s full report on LLY stock, click here.
More about Eli Lilly & Co
YTD Price Performance: 28.83%
Average Trading Volume: 4,004,522
Technical Sentiment Signal: Buy
Current Market Cap: $913.8B